Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) has earned an average recommendation of “Hold” from the twenty-two ratings firms that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and twelve have assigned a buy recommendation to the […]